Pub. Date : 2012 Dec
PMID : 22448738
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Avanafil is a potent selective phosphodiesterase type 5 (PDE5) inhibitor newly developed for treating erectile dysfunction (ED). | avanafil | phosphodiesterase 5A | Homo sapiens |
| 2 | Avanafil is a potent selective phosphodiesterase type 5 (PDE5) inhibitor newly developed for treating erectile dysfunction (ED). | avanafil | phosphodiesterase 5A | Homo sapiens |
| 3 | Preclinical and clinical phase I studies showed that avanafil had enhanced selectivity, faster onset of action and a favourable side-effect profile relative to currently available PDE5 inhibitors. | avanafil | phosphodiesterase 5A | Homo sapiens |
| 4 | OBJECTIVE: To evaluate the efficacy and safety of avanafil, a new potent selective phosphodiesterase type 5 (PDE5) inhibitor, in patients with erectile dysfunction (ED). | avanafil | phosphodiesterase 5A | Homo sapiens |
| 5 | OBJECTIVE: To evaluate the efficacy and safety of avanafil, a new potent selective phosphodiesterase type 5 (PDE5) inhibitor, in patients with erectile dysfunction (ED). | avanafil | phosphodiesterase 5A | Homo sapiens |